LISTED medicinal cannabis company AusCann has appointed a new Chief Medical Advisor, Dr Marc Russo, to help accelerate its medical engagement program.
Russo will aid the business to pursue its medical strategy, which includes medical education, clinical evidence generation and clinical insights, as the company develops new product pipelines and intellectual property.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Mar 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 20
